Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06424899
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-05-10
Brief Title:
A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC
Sponsor:
Zeng Jian
Organization:
Zhejiang Cancer Hospital
Organization Data
Organization:
Zhejiang Cancer Hospital
Class:
OTHER
Study ID:
IRB-2024-106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zeng Jian
Lead Sponsor Class:
OTHER
Responsible Party:
Zeng Jian
Responsible Party Title:
Archiater Thoracic Surgery Department
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Zhejiang Cancer Hospital
Old Name:
None
Old Organization:
None